This has been sitting down here accumulating. This is a company getting its profit from medical patents awaiting FDA approval for its surgical technology that will increase recovery time for patients.... I'm here for it.
Hello my beauties.
I think MRNA has entered a distribution range, as the ST (second test) seemed to be pretty weak, and the price is now showing weakness below the trading range. We are going to wait for further developments in price action and eventually take a trade on the final LPSY. For those of you who like trading ranges, this might be a juicy opportunity....
Invitae offers gene panels and single-gene testing for a broad range of clinical areas including hereditary cancer, cardiology, neurology, pediatric genetics, metabolic disorders, immunology, and hematology.
The price is on a strong weekly pattern, decent long opportunity on probable bullish rebound.
Just did a basic fib retracement on ISRG using that last low. Looks like the 50 fib line presents a consistent area of traffic and previous support. It tested the 236 fib area weeks ago and after managing to break through and hold, the stock made new highs. After failing to retest those highs at the end of the week, it settled back at the recent levels just shy...
My favorite new indie stock, Seelos Therapeutics, was recently upgraded from a price target of $4.70 to a whopping $15.
For this to happen, it may have to beat some bears (in SPY) and sharks (in short interest).
Short interest in the stock is down, with most shares not available to short. This is positive and bullish for shorter term.
The stock market looks to...
"Ultrasound designed for the future."
"Experience a groundbreaking ultrasound solution and the world’s only single-probe, whole-body handheld device, powered by Ultrasound-on-Chip™ technology. Butterfly transforms complex processes into one connected POCUS system to help you offer better, more efficient care."-Butterfly Network Inc
That is info from their...
Hi. In this 1D chart I've plotted a few things: the recent MA 56 crossing that marked a trend turn, the approaching resistance zone from November last year and an interpretation of the movements since then as Elliott Waves.
You can also see:
There is still rooms for the Williams 224 to climb further.
The historical volatility is lower than it was in...
The polarization machine emits electromagnetic (EM) waves in the form of packets of quantum energy (""photons"") with a frequency that resonates with the molecular frequency of targeted compounds"
85% below the July peak of last year and 99% below its all-time high.
Orbiting a major support level around $4.
A capital injection began in mid-November that is still not properly reflected in price.
Stochastic at the oversold point and RSI close to touching it.
It could give the surprise of giving a significant bounce to the marked lines.
The risk is that...
It seems to me that it is looking for a reversal.
The price has already been rejected 2 times by touching its EMA.
It has resistance at $19.5 - 20.
30% below its August high.
It can go as high as $25.
"Fonar Corporation designs, develops, manufactures, and sells magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human disease."
if market keep is bullish euphorique structure, we are close to start the 3 wave that is extensive.
with covid trubbles and vaccination approval we can see that the probable futur trend will be bullish.
investor tend to go with hot stocks or easy to guest safe heaven sector, in the case of a global pendemie the one industry that cannot suffer from...